You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 3, March 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (67)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Breast Cancer
 •Women's Health
 •Women's Health, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Axillary Sentinel Lymph Node Biopsy in Patients With Pure Ductal Carcinoma In Situ of the Breast

Mattia Intra, MD; Paolo Veronesi, MD; Giovanni Mazzarol, MD; Viviana Galimberti, MD; Alberto Luini, MD; Virgilio Sacchini, MD; Giuseppe Trifirò, MD; Oreste Gentilini, MD; Giancarlo Pruneri, MD; Paola Naninato, MD; Fabio Torres, MD; Giovanni Paganelli, MD; Giuseppe Viale, MD, FRCPath; Umberto Veronesi, MD, PhD

Arch Surg. 2003;138:309-313.

Hypothesis  A sentinel lymph node (SLN) biopsy should not be considered a standard procedure in the treatment of all patients with ductal carcinoma in situ (DCIS) of the breast if the lesion is completely excised by radical surgery and there are free margins of resection.

Design  Prospective case series.

Setting  Department of breast surgery of a comprehensive cancer center.

Patients  From January 1, 1998, to December 1, 2001, 223 unselected consecutive patients affected by pure DCIS of the breast underwent an SLN biopsy.

Results  Metastases in the SLN were detected in 7 (3.1%) of the 223 patients, and complete axillary dissection was subsequently performed in all these patients but 1. Of these 7 patients, 5 had only micrometastases in the SLNs; and in the 6 patients treated with complete axillary dissection, the SLN was the only positive node.

Conclusions  Because of the low prevalence of metastases, an SLN biopsy should not be considered a standard procedure in all patients with DCIS. In patients with pure DCIS in whom the lesion is completely excised by radical surgery, an SLN biopsy could be avoided. It could be considered in patients with DCIS undergoing mastectomy, in whom there exists a higher risk of harboring an invasive component using definitive histologic features, like large solid tumors or diffuse or multicentric microcalcifications; in these patients, an SLN biopsy cannot be performed at a later operation. Complete axillary dissection may not be mandatory if the SLN is micrometastatic.


From the Departments of Breast Surgery (Drs Intra, P. Veronesi, Galimberti, Luini, Gentilini, Naninato, Torres, and U. Veronesi), Pathology and Laboratory Medicine (Drs Mazzarol, Pruneri, and Viale), and Nuclear Medicine (Drs Trifirò and Paganelli), European Institute of Oncology, Milan, Italy; Department of Pathology, University of Milan School of Medicine, Milan (Drs Mazzarol, Pruneri, and Viale); and the Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY (Dr Sacchini).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Surgery
Arch Surg. 2003;138(3):237.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Current Treatment and Clinical Trial Developments for Ductal Carcinoma In Situ of the Breast
Boughey et al.
The Oncologist 2007;12:1276-1287.
ABSTRACT | FULL TEXT  

Axillary Sentinel Lymph Nodes Can Be Falsely Positive Due to Iatrogenic Displacement and Transport of Benign Epithelial Cells in Patients With Breast Carcinoma
Bleiweiss et al.
JCO 2006;24:2013-2018.
ABSTRACT | FULL TEXT  

Lymphatic Mapping and Sentinel Lymph Node Biopsy for Breast Cancer: Developments and Resolving Controversies
Kuerer and Newman
JCO 2005;23:1698-1705.
FULL TEXT  

Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast
Intra et al.
JNCI J Natl Cancer Inst 2004;96:1110-1111.
FULL TEXT  

Ductal Carcinoma in Situ of the Breast
Burstein et al.
NEJM 2004;350:1430-1441.
FULL TEXT  

Invited Commentary * Authors' Response
Dillehay et al.
RadioGraphics 2004;24:139-145.
FULL TEXT  

The Selective Use of Sentinel Node Biopsy in Ductal Carcinoma In Situ
Bleicher and Giuliano
Arch Surg 2003;138:489-489.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.